FLEXcon Delivers FDA UDI Compliant Label Substrates to Medical Device Market

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SPENCER, Mass.--(BUSINESS WIRE)--FLEXcon®, an innovator in adhesive coating and laminating, today announced the launch of FLEXcon® MedFLEX™, a line of label substrates that meets all performance criteria required by the Food and Drug Administration’s (FDA) proposed unique device identifier (UDI) rule. The legislation will require Class II and III medical devices distributed in the U.S. to carry a unique numeric or alphanumeric code with an identifier specific to each device or model as well as an identifier with current production information. The FLEXcon MedFLEX line is UL-certified in accordance with UL/IEC 60601-1 3rd edition marketing durability rub tests. All products are available for immediate UL adoption.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC